NASDAQ: BBIO · Biotechnology
Over the past week, BridgeBio Pharma (BBIO) racked up about 23 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 29% bullish but is far apart: News runs 45% bullish while Reddit sits at just 0%. Wall Street is more constructive, with 19 of 22 analysts rating BBIO a buy.
There is little buzz around BBIO this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 86% buy share sits next to a crowd that ranges from Reddit at 0% to News at 45%. No other tracker puts the two side by side.
Across 22 analysts the consensus is a Strong Buy: 19 buy calls against 0 sell, with an average 12-month price target of $109.05.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is mixed and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 57 points above the crowd average of 29%, the professionals are more constructive than retail. The split is inside the crowd: News reads 45% bullish while Reddit sits at 0%, a 45-point spread that single-source trackers miss.
Over the 30-day window, BridgeBio Pharma (BBIO) buzz held subdued around 28.7 while the price drifted down 9.8% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 3.1M shares. Updated Oct 10, 2026. Over the last 7 trading days, BBIO lost 2.3%. Buzz activity in the recent week averaged 38.0 and was relatively stable, swinging between 27.7 and 46.9. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 13 of the 15 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for BBIO and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live BBIO sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 10, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (19 / 3 / 0) |
| Crowd bullish (7d) | 29% |
| Avg price target | $109.05 |
| Most bullish source | News, 45% |
| Most bearish source | Reddit, 0% |
| Sentiment spread | 45 pts |
| Mentions (7d) | 23 |
| Market cap | $12.71B |
| EPS · Beta | -$3.56 · 1.0 |
| Revenue (TTM) | $713.1M · -97% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, BridgeBio Pharma (BBIO) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 29% bullish across 3 active sources. Those sources contribute 23 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around BridgeBio Pharma (BBIO) is fairly quiet with 0 mentions over the last 7 days; the 30-day context spans 2 tracked subreddits. The 7-day tone is 0% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on BridgeBio Pharma (BBIO), averaging 29% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 45% bullish and Reddit at 0%, a 45-point spread. On the professional side, 19 of 22 analysts rate BBIO a buy.
Of the 22 analysts covering BridgeBio Pharma (BBIO), 19 rate it a buy, 3 a hold and 0 a sell, for a strong buy consensus. The average price target is $109.05. That puts the street ahead of the crowd, which averages 29% bullish.
BridgeBio Pharma (BBIO)'s cross-source average is bearish at 29% bullish. All 3 tracked sources lean bearish. X reads 42% bullish, News reads 45% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for BridgeBio Pharma (BBIO) at 29% bullish. All 3 tracked sources lean bearish. The most bearish reading is reddit at 0% bullish. 3-day activity momentum is falling on X, while news activity is rising. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 12 mentions (52% of total volume). News contributes 11 mentions. The cross-source average is bearish at 29% bullish, while news is the only source with rising 3-day activity. All 3 tracked sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. BBIO's sell signal at 93/100 conviction reflects a bearish cross-source average at 29% bullish. All 3 tracked sources lean bearish. It is a research shortcut, not financial advice.
The BBIO sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key